April 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreApril 21, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreApril 21, 2026
Projections indicate that, GMP peptides industry is projected to rise from USD 1.3 billion in 2024 to USD 2.9 billion by 2034, reflecting a CAGR of 8.35% over the next decade. The growing demand for peptide drugs and technological advancements drives the global market. North America dominated the global market due to the presence of key players and...
April 21, 2026
The market is experiencing strong growth due to the rising demand for molecular diagnostics, increasing genomic research, and advancements in personalized medicine. North America dominated the market, supported by its advanced healthcare infrastructure, growing investments in biotechnology, and early adoption of innovative diagnostic technologies....
April 21, 2026
According to market projections, the monoclonal antibody discovery platform sector is expected to grow from USD 3.66 billion in 2025 to USD 11.93 billion by 2035, reflecting a CAGR of 12.55% that covers manufacturers, suppliers, value chain insights, and revenue forecasts. North America holds 35% share, APAC grows fastest (China, India), and Europe...
April 21, 2026
The antibody optimization service market was valued at USD 2.77 billion in 2024 and is projected to reach USD 6.07 billion by 2034, growing at a CAGR of 8.45%. The report covers technology segments (CRISPR, TALEN, ZFN) and applications (therapeutics, biotechnology). Asia-Pacific is the fastest-growing region among NA, EU, APAC, LA, and MEA due to r...
April 21, 2026
The nanobiotechnology market was valued at USD 172.81 billion in 2024 and is projected to reach USD 420.2 billion by 2034, growing at a CAGR of 9.37%. The report covers segments by material, product type, and end-user, with regional insights across North America (42%), Europe, APAC, Latin America, and MEA. It includes value chain and competitive an...
April 21, 2026
Projections indicate that, the global cell culture microcarriers market will increase from USD 3.18 billion in 2024 to USD 7.2 billion by 2034, experiencing a CAGR of 8.54% over the next 10 years.The growing research activities and advancements in cell culture technologies bolster market growth. North America dominated due to the growing demand for...
April 21, 2026
The mRNA Quality Monitoring market is projected to grow from USD 1.37 billion in 2025 to USD 2.5 billion by 2034, expanding at a CAGR of 6.97%. This report provides a full overview of market size, segmentation, and competitive analysis, covering all major regions North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. ...
April 21, 2026
Based on market forecasts, the global cell line cryopreservation market, projected at USD 5.39 billion in 2025, is expected to reach USD 13.97 billion by 2034, growing at a CAGR of 11.16% over the forecast period. The cell line cryopreservation market is growing as increasing demand for cryopreservation for personalized medicine, regenerative and c...
April 21, 2026
Based on market forecasts, the global gene vector market, projected at USD 9.61 billion in 2025, is expected to reach USD 64.38 billion by 2035, growing at a CAGR of 21% over the forecast period. The gene vector market is growing due to rising demand for gene and cell therapy. North America’s dominance can be attributed to the rising demand f...
April 21, 2026
According to market projections, the global rare cell isolation market, valued at USD 2.25 billion in 2025, is anticipated to reach USD 5.73 billion by 2035, growing at a CAGR of 9.79% over the next decade. The rising prevalence of genetic disorders and the growing demand for personalized medicines drive the global market. North America dominated d...